Characteristic | n = 10 |
---|---|
Gender, female/male | 7/3 |
Age in years, range (mean) | 48-74 (65.0) |
Disease duration in years, range (mean) | 1-18 (10.6) |
CRP in mg/dL, range (mean) | 0.05-3.34 (0.66) |
ESR in mm/hour, range (mean) | 1-83 (20.8) |
Rheumatoid factor, positive/negative | 9/1 |
Anti-CCP antibody in U/mL, range (mean) | 0.6-100 (37.8) |
MMP-3 in ng/mL, range (mean) | 38.9-525.7 (222) |
Steinbrocker stage, I/II/III/IV | 0/5/3/2 |
Patients using DMARDs and biologics | Â |
   Methotrexate | 7 |
   Infliximab | 1 |
   Etanercept | 2 |
   FK506 | 2 |
Patients using oral steroids | 5 |